Histotripsy tumor ablation-mediated immune-stimulation

Project Name: Histotripsy tumor ablation-mediated immune-stimulation
Status: Active
Primary Site: University of Michigan
Sponsor Organization: Focused Ultrasound Foundation
Funded Date: Nov 06, 2019
Funding Period: Nov 06, 2019 - Nov 06, 2020
Funding Program: Immunotherapy
Category: Pre-Clinical
Amount Awarded: $112,008.00


Immunotherapy has radically altered the prognostic outlook for patients with relatively immunogenic cancers like melanoma and lung cancer; however, cancers that are less conspicuous to the immune system have been obstinately resistant to immunotherapy. Histotripsy uses high-intensity, focused ultrasound pulses to generate inertial cavitation to cause cellular disruption, liquefying the target tumor to acellular debris. Preliminary results show that histotripsy stimulates local, regional, and systemic immune responses; histotripsy stimulates abscopal effects in the immunosuppressive murine hepatocellular model. We hypothesize that histotripsy can break the ability of cancers to avoid immune detection, sensitizing previously resistant cancers to immunotherapy.

Contact Roles


No reports found.

The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903
Whitelist Instructions